chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient is fully vaccinated.  COVID positive 12/27/2021.  Presented to the ED 1/1//2022.  51-year-old female with history of asthma  presenting with lung tightness consistent with her asthma.She's been having occasional dry cough and chest tightness due to her asthma. She has been using her albuterol at home. She's not having any chest pain, abdominal pain, vomiting, diarrhea.She was in no respiratory distress, no hypoxia or tachypnea. Afebrile. Recommended continuing using her asthma medications at home and will be prescribed a course of prednisone. She will be given referral to clinic for monoclonal antibody infusion treatment. Discharged stable
Information has been received from a nurse concerning a male who in July 2008, was vaccinated with ZOSTER (Oka/Merck) (lot # not provided).  In the week of 10-NOV-2008, the patient experienced itchy rash.  It was unspecified if the patient sought medical attention.  At the time of the report, on 14-NOV-2008, the outcome of the patient was unknown.  This is one of two reports received from the same source.   Additional information has been requested.
Information has been received from a physician through a pregnancy registry concerning a female who was vaccinated in 2000 with two doses of varicella virus vaccine live six months apart. Subsequently a titer was checked and was negative. Unspecified medical attention was sought. On 06Jun05, the mother was picking up her four year old from daycare and was exposed to chickenpox. On 09Jun05 she was vaccinated with another dose of varicella virus vaccine live while pregnant. Unspecified medical attention was sought. On 10Jun05 she was induced and vaginally delivered a healthy baby boy. The mother was given after delivery. As of 14Jun05, the infant was five days old and had been breast feeding for five days. Additional information has been requested.
Per history provided by patient's daughter: Patient received J&J COVID-19 vaccine on April 5, 2021. As early as 4/6/21, patient developed a slow and progressive functional decline leading to admission at healthcare facility on 4/19 for left subdural hematoma. Patient was noted to have slurred speech, unsteady gait and increased forgetfulness. Prior to initial visit at healthcare facility, patient kept repeating questions and asking where he was. Patient was admitted for neurosurgery evaluation but no operative intervention was indicated at this time. patient monitored inpatient for potential concurrent AKI with possible UTI. Patient give IM Rocephin and monitored daily before discharge.
Rapid heartbeat; Unusual heart palpitations; Elevated blood pressure; This is a spontaneous report received from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via unspecified route of administration in the left arm on 22Mar2021 at 09:15 (at the age of 67-year-old) as single dose for COVID-19 immunisation. Medical history included blood pressure high (HBP). Concomitant medications included calcium (MANUFACTURER UNKNOWN), Colecalciferol (VITAMIN D3), enalapril (MANUFACTURER UNKNOWN), hydrochlorotiazid (HCTZ), enalapril maleate (MANUFACTURER UNKNOWN), all from an unknown date for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via unspecified route of administration in the left arm on 01Mar2021 at 09:30 (at the age of 67-year-old) as single dose for COVID-19 immunisation.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced rapid heartbeat, unusual heart palpitations (less than 4 hours), and elevated blood pressure on 22Mar2021 at 22:00. The patients resting heart rate 102 and elevated blood pressure of 157/86 (units unspecified). Further it was reported that the symptoms started at 2200 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of rapid heartbeat, unusual heart palpitations, and elevated blood pressure was recovered on unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) in an elderly female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.            No concomitant medications were reported.  On an unknown date, the patient received first dose of Moderna COVID-19 vaccine (Intramuscular) one in once.  No treatment medications were reported.  The reporter's causality for the event of COVID-19 with Adalimumab Solution for Injection was not provided.  The reporter's causality for the event of COVID-19 with Moderna COVID-19 vaccine (Elasomeran) was reasonable possibility.
Brain stem ischemic stroke in PONS area. Seen by a neurologist. 7 speech therapy sessions. Recovery of speech to some extent. Recovery of right side movement.  1 physical therapy session. 4 occupational therapy sessions. Permanent impairment of full singing ability as a semi professional singer. Handicapped driver. Impairment of emotional control.
Vaccine reaction (L) shoulder post PPV (pain, warmth, swelling & tight). Treated with TYLENOL # 3) Ibuprofen & ice compress
Achy muscles, stiff neck and back, extreme fatigue, nausea, migraines, diarrhea, ringing in ears, sharp stabbing pains in belly, severe abdominal cramping, numbness and tingling in limbs, impaired thinking, aversions to foods, strong aversion/nausea upon smelling strong scents, trouble sleeping, fevers.  4/2/2008 MR received for OV 3/27/2008 and PMH back to 12/2006. Pt presented to office with c/o ? reaction to 3rd Gardasil vax. Pt reports migraines x 10 in the week following vax, now with constant, throbbing pain in the R eye area with pressure.  Pt also reports diarrhea and abd cramping, 10 stools yesterday.  Legs go numb during BM. Smells bother pt now. Pt reports fevers. Temp 99.8 at OV.  Pt reports paresthesias in the L leg which began 3/25/08. Pt also reports weakness, fatigue and twitching.  PE WNL. Assessment:  R Frontal Headaches.  Abdominal Pain, cramping & diarrhea. Paresthesias of the legs. Tag2 received from PCP (308590 to be linked). 4/7/08 RN in PCP office reports pt's sx have improved with Medrol dose pack.
Shingles; Redness with itching all over her body / redness of her face, eyes, eyelids, inside of her thumbs, right side torso; Itching all over her body / Itching at right ankle, back of right leg, upper back, and it may have come around to her front shoulder blade area, and right side torso; Rash on upper back and shoulder blade; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 86-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st July 2018, the patient received the 1st dose of Shingrix (intramuscular). On 31st July 2018, 10 days after receiving Shingrix, the patient experienced shingles, generalized erythema, generalized pruritus and rash. The patient was treated with cetirizine hydrochloride (Cetrizine). Shingrix was discontinued. On an unknown date, the outcome of the shingles was unknown and the outcome of the generalized erythema, generalized pruritus and rash were resolved with sequelae.   The reporter considered the shingles, generalized erythema, generalized pruritus and rash to be related to Shingrix.  Additional details were provided as follows: The patient stated that had redness with itching all over her body. The patient specifically mentioned redness of her face, eyes, eyelids, inside of her thumbs, right side torso. The patient also mention itching at injection site, right ankle, back of right leg, upper back, and it may have come around to her front shoulder blade area, and right side torso. The patient also had rash on upper back and shoulder blade. The patient had not received the second dose of shingrix because her healthcare professional told her she is not a candidate for the second dose due to the reaction she experienced with the first dose. The patient had 2 outbreaks of shingles after receiving the first dose. The patient did not consent to follow up.
On Day 4, pt called stated she went to ER for  severe swollen arm with redness around the injection site. Pt also reported of swollen lymph nodes on  her throat, in which she believed it was an  anaphylactic shock. Pt then was prescribed antibiotics and Benadryl for the symptoms.
Tingling hands and feet started same day. Continues off and on for 6 weeks now.  Chest pain upon even mild exertion like walking around the block. Lasted for a few weeks. Right arm bone pain severe lasted for about 3 weeks Spine felt swollen near coccyx/sacrum and C7-C6 pain. Feeling of Lower spine swelling and pain started less than 24 hrs. after. Lasted approx 2 weeks. Extreme tiredness lasted 2 weeks Baseball shaped raised area on chest near right arm(vaccinated arm) started perhaps a week in and lasted about a week.
Patient received immunizations on 9/25/17 and on 9/26/17 called pharmacy to report fever and redness at injection site. Pharmacist advised patient to contact her doctor for fever and that redness upon injection site is normal site reaction. Patient reported on 9/28/17 to pharmacist that she did go to her doctors office 9/26/17 and while there she fell, and was transported to hospital for fall.  Patient is now at hospital being treated for cellulitis.
Pt's arm became hot and inflammed on the afternoon, post vax. A rash appeared shortly afterwards, becoming pustular and traveling down the entire left arm. Rash covered entire arm and was very inflammed and uncomfortable. Pt went to PCP on 10/22/01 and was given an injection of Kenalog and a Medrol Dosepak. At completion of Dosepak, all inflammation had disappeared but evidence of the rash still remains as of 11/13/01.
As soon as I gave the vaccine the patient's skin because raised in a white circle (about 1/2 inch wide) with a little bit of redness at the injection site. She also said it was more painful than it had been in the past. We sat and monitored the spot and the swelling/induration did seem to decrease. Followed up with patient about an hour later and she said the raised area was still visible and there was a little bit of redness.
reaction to the Moderna booster; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (reaction to the Moderna booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (reaction to the Moderna booster). At the time of the report, VACCINATION COMPLICATION (reaction to the Moderna booster) outcome was unknown.            No relevant concomitant medications were reported. Treatment information was unknown.
A few hours after the vaccine i had a headache and took Aleve which did not help. The next day i had a fever of 99.1-99.7 most of the day including body aches, chills, and exhaustion. It let up around 7pm 3/7/21 and on 3/8/21 i felt a little weak but mostly back to normal. No symptoms left on 3/9/21
1 cm red around injection site in all 4 areas vaccines given. Rash on face and forehead also noted - BENADRYL administered pt observed for 25 minutes.
This is a 60y.o. male with PMH of lewy body dementia and hypertension  presented to the ED with chief complaint of an unwitnessed fall.  Pt is AOx0-1 at baseline and limited history is provided by the patients brother. Pt lives in a memory care unit and was found down by staff. Patient was noted to a have a bump on the right side of his head. Patient was noted to favor his right arm by emergency room staff. Patient was hospitiliazed on Sunday and diagnosed with coronavirus. He discharged Monday as he did not require supplemental oxygen.   ED Vitals: BP 105/64, Temp 100.3, SPO2 93% on RA, HR 57.   Labs significant for hgb of 10.7, a urinalysis suggestive of a UTI with 11-20 WBC, 5 ketones, 3-5 hyaline casts, and 1+ bacteria.   CT trauma: No acute intracranial process, Nonspecific white matter changes, likely secondary to chronic small vessel ischemic disease. Small amount of right posterior parietal scalp soft tissue swelling and paranasal sinus disease.   CT Cervical spine: No evidence of cervical spine fracture; no significant interval change. Mild degenerative disc disease most pronounced at C4-C5 with at least mild spinal canal stenosis.    Right humerus x-ray: No evidence of fracture or dislocation Right elbow x-ray: No evidence of fracture or dislocation Chest x-ray: No acute process Pelvis x-ray: No evidence to suggest fracture  tested positive at Hospital 1/2/2022
had hives, like a rash/a rash on her face and her legs/hives on her face that were red and bumpy; her eye looks like a bee stung her eyelid,  it is swollen; her legs were itching; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient 's medical history and concomitant medications were not reported. It was reported that patient had hives, like a rash and today, eye looks like a bee stung her eyelid, swollen. Rash on her face and her legs and her legs were itching, it was like hives on her face that were red and bumpy. They are not as bumpy but it is still red. Patient was taking Prednisone but not sure if that is why its getting a little bit better but it is still really red and itching and the swollen eye. Outcome of events was unknown.
Had MMR 15APR91 on 19APR91 developed constant h/a, cramping & diarrhea;
Pt had shot yesterday felt fine all day, this morning has some itching on mid to left lower back. As the day went on it became a burning/pain sensation when she looked she noticed a rash as well that looked like shingles.
Received vaccines after a temperature excursion; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 62-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 01-MAR-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: Received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023054677:same reporter US-GSK-US2023AMR055743:same reporter
EXTREME ITCHING HANDS AND FEET WHICH PROGRESSED TO RAISED HIVES, THROAT SWOLLEN A LITTLE.
Pt reported some redness and itching on 5/12/2006 upon awakening 5/13/06 noted severe swelling, redness, increased heat to touch extending from shoulder to elbow; went to emergency dept. Rec. ibuprofen 600gm a 6 hrs, Oxycodin prn pain, Benadryl 50gm q 6 hrs, seen on 5/15/06 at clinic, condition resolving.
severe h/a, extreme muscle pain, muscle spasm, dry mouth, dizziness, lack of energy-temp of 101-102;could not dress or walk on own;rx APAP, valium;
Heart palpitations worsening to the point where they are making me cough occasionally; cough occasionally; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via unspecified route of administration in right arm on 06Mar2021 at 10:15 hours (at the age of 62-years) as a single dose for COVID-19 immunisation. Medical history included premature ventricular contractions (PVCs). It was reported as heart PVCs much lighter than what she had now. Concomitant medications included ESTRING and TYLENOL PM. The patient received these medications within 2 weeks of vaccination. The patient was allergic to morphine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 14Mar2021 at 08:00 hours, the patient had heart palpitations worsening to the point where they were making her cough occasionally. The clinical outcome of the events palpitations aggravated and cough was not resolved.   No follow-up attempts are possible. No further information is expected.
The first adverse I notice was headaches,it raised by blood pressure, Blurry eyes, and now I just got diagnosed with Deep Vain Thrombosis . I am sure this all because of the Johnson and Johnson vaccine.
dizziness; no appetite; could not work; chills; fever; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), DECREASED APPETITE (no appetite), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (could not work), CHILLS (chills) and PYREXIA (fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Oct-2021, the patient experienced DIZZINESS (dizziness), DECREASED APPETITE (no appetite), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (could not work), CHILLS (chills), PYREXIA (fever), NAUSEA (nausea) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) on 02-Oct-2021 at a dose of 4 Tylenols. On 03-Oct-2021, CHILLS (chills) had resolved. On 04-Oct-2021, DIZZINESS (dizziness) and NAUSEA (nausea) had not resolved, DECREASED APPETITE (no appetite), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (could not work) and HEADACHE (headache) had resolved. At the time of the report, PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported.   This case was linked to MOD-2021-340861 (Patient Link).
This spontaneous report was received from a medical assistant concerning a patient who on 29-NOV-2010 was vaccinated with the first dose of GARDASIL (dose, route and lot # not provided), on 07-FEB-2011 received the second dose of GARDASIL (dose, route and lot # not provided) and on 11-APR-2011 received the third dose of GARDASIL (dose, route and lot # not provided). No other co-suspects were reported. No concomitant medications were reported. The medical assistant stated that on 10-JUL-2012, the patient received the fourth dose of GARDASIL (dose, route and lot # not provided). No adverse reactions were reported. Additional information is not expected.
Patient received 2nd dose of Pfizer vaccine 14 days after 1st dose instead of the earliest possible day (day 17).  No adverse reaction occurred that we are aware of.
szs-abn EEG & thin corpus collosim-started on ACTH-now on Tegretol; In April had severe developmental delay & poor weight gain
left tricep was swollen, red and painful. no swelling or redness at administration site. started on 9/27. she noticed it when she woke up that morning. she presented on 9/28 feeling better, but was still swollen, red and painful
Swollen right armpit; Sore spine area of back; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 10Apr2021 at 12:00 (at the age of 27-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported and the patient had a history of allergy to peanuts and tree nuts. Concomitant medications included paracetamol (TYLENOL) for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021 at 12:00, the patient experienced swollen right armpit and sore spine area of back. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of the events swollen right armpit and sore spine area of back were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Fever times 2 days, erythemateous area right thigh, indurated, upper respiratory "cold" symptoms.  Amoxicillin 250mg/5ml give: 4ml po q 8 hours for 1 week.  Rondec drops 0.75ml po qid prn.
Fever, arm tenderness, joint pain, achy, nausea, vomiting, headache, chills
administered an initial dose of VARN AX on an unspecified date while pregnant; No adverse effects; This spontaneous report was received from a nurse referring to a 28 years old female patient. There was no information about the patient's concurrent conditions, drug reactions, allergies, medical history, and concomitant therapies provided.    On an unknown date, the patient was administered an initial dose of varicella virus vaccine live (oka/merck)(VARIVAX)(dose, route, lot # and expiration date were not reported) for prophylaxis while pregnant (Maternal exposure during pregnancy). The last menstrual period (LMP) and estimated date of delivery (EDD) were unknown. The pregnancy outcome was pending. The fetal outcome was unknown. No adverse effects.
no adverse effects; patient have been administered doses of improperly stored vaccines; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided.On 25-MAR-2020, the patient was vaccinated with improperly stored dose of hepatitis a vaccine, inactivated(VAQTA), 0.5 milliliter, intramuscular in the left thigh for prophylaxis(lot # reported as 747P5 with expiration date not provided).No adverse event was provided. This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2008USA008876: US-009507513-2008USA008885: US-009507513-2008USA008883: US-009507513-2008USA008889: US-009507513-2008USA008890: